vosoritide

Italy

Drugs containing this active substance

  • VOXZOGO

    It is used for the treatment of achondroplasia in patients aged 4 months or older whose bones are still growing. It is indicated only in cases of achondroplasia caused by FGFR3 gene mutations confirmed by genetic testing.

    Form: solution for injection, powder and solvent

    Active substance Dosage
    vosoritide -

    ATC: M05BX07

    Manufacturer: BIOMARIN INTERNATIONAL LIMITED